IL129166A0 - Hydroxamic acid derivatives - Google Patents

Hydroxamic acid derivatives

Info

Publication number
IL129166A0
IL129166A0 IL12916697A IL12916697A IL129166A0 IL 129166 A0 IL129166 A0 IL 129166A0 IL 12916697 A IL12916697 A IL 12916697A IL 12916697 A IL12916697 A IL 12916697A IL 129166 A0 IL129166 A0 IL 129166A0
Authority
IL
Israel
Prior art keywords
acid derivatives
hydroxamic acid
hydroxamic
derivatives
acid
Prior art date
Application number
IL12916697A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620572.9A external-priority patent/GB9620572D0/en
Priority claimed from GBGB9706667.4A external-priority patent/GB9706667D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL129166A0 publication Critical patent/IL129166A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12916697A 1996-10-02 1997-09-30 Hydroxamic acid derivatives IL129166A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9620572.9A GB9620572D0 (en) 1996-10-02 1996-10-02 Organic compounds
GBGB9706667.4A GB9706667D0 (en) 1997-04-02 1997-04-02 Organic compounds
PCT/EP1997/005376 WO1998014424A1 (fr) 1996-10-02 1997-09-30 Derives d'acide hydroxamique

Publications (1)

Publication Number Publication Date
IL129166A0 true IL129166A0 (en) 2000-02-17

Family

ID=26310147

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12916697A IL129166A0 (en) 1996-10-02 1997-09-30 Hydroxamic acid derivatives

Country Status (29)

Country Link
EP (1) EP0929517B1 (fr)
JP (1) JP3444898B2 (fr)
KR (1) KR20000048811A (fr)
CN (1) CN1101807C (fr)
AR (1) AR009103A1 (fr)
AT (1) ATE219050T1 (fr)
AU (1) AU726065B2 (fr)
BR (1) BR9712255A (fr)
CA (1) CA2267415A1 (fr)
CO (1) CO4900034A1 (fr)
CZ (1) CZ113999A3 (fr)
DE (1) DE69713354T2 (fr)
DK (1) DK0929517T3 (fr)
ES (1) ES2178759T3 (fr)
HK (1) HK1021637A1 (fr)
HU (1) HUP9903892A3 (fr)
ID (1) ID22212A (fr)
IL (1) IL129166A0 (fr)
MY (1) MY127926A (fr)
NO (1) NO313457B1 (fr)
NZ (1) NZ334908A (fr)
PE (1) PE2099A1 (fr)
PL (1) PL188518B1 (fr)
PT (1) PT929517E (fr)
RU (1) RU2196131C2 (fr)
SI (1) SI0929517T1 (fr)
SK (1) SK43099A3 (fr)
TR (1) TR199900725T2 (fr)
WO (1) WO1998014424A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056353A2 (fr) * 2002-12-20 2004-07-08 Novartis Ag Dispositif et procede permettant d'administrer des inhibiteurs de mmp
EP2287326A1 (fr) 2003-08-08 2011-02-23 Arriva Pharmaceuticals, Inc. Procédés de production de protéines dans la levure
EP1737499A4 (fr) 2004-03-09 2009-07-22 Arriva Pharmaceuticals Inc Traitement de la bronchopneumopathie chronique obstructive par inhalation a faible dose d'inhibiteur de protease
CN1951912B (zh) * 2005-10-18 2010-05-05 上海五洲药业股份有限公司 手性脂环烃异羟肟酸衍生物的制备方法
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
US10975019B2 (en) * 2016-04-18 2021-04-13 Vivoryon Therapeutics Ag Inhibitors of meprin α and β

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
CZ290145B6 (cs) * 1994-01-20 2002-06-12 British Biotech Pharmaceuticals Limited Inhibitory metaloproteinázy
EP0740655B1 (fr) * 1994-01-22 1999-10-20 British Biotech Pharmaceuticals Limited Inhibiteurs de metalloproteinase
GB9416897D0 (en) * 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
NZ334908A (en) 2000-10-27
HK1021637A1 (en) 2000-06-23
BR9712255A (pt) 1999-08-24
AU726065B2 (en) 2000-10-26
PE2099A1 (es) 1999-02-08
DE69713354T2 (de) 2002-12-05
SK43099A3 (en) 1999-08-06
AU4706897A (en) 1998-04-24
RU2196131C2 (ru) 2003-01-10
ES2178759T3 (es) 2003-01-01
NO991559L (no) 1999-03-30
CN1232447A (zh) 1999-10-20
EP0929517A1 (fr) 1999-07-21
DE69713354D1 (de) 2002-07-18
CN1101807C (zh) 2003-02-19
JP2000508338A (ja) 2000-07-04
HUP9903892A2 (hu) 2000-03-28
EP0929517B1 (fr) 2002-06-12
PT929517E (pt) 2002-10-31
DK0929517T3 (da) 2002-10-07
CA2267415A1 (fr) 1998-04-09
CZ113999A3 (cs) 1999-06-16
HUP9903892A3 (en) 2000-04-28
NO991559D0 (no) 1999-03-30
MY127926A (en) 2006-12-29
SI0929517T1 (en) 2002-10-31
PL332477A1 (en) 1999-09-13
ID22212A (id) 1999-09-16
JP3444898B2 (ja) 2003-09-08
PL188518B1 (pl) 2005-02-28
AR009103A1 (es) 2000-03-08
TR199900725T2 (xx) 1999-07-21
KR20000048811A (ko) 2000-07-25
CO4900034A1 (es) 2000-03-27
NO313457B1 (no) 2002-10-07
WO1998014424A1 (fr) 1998-04-09
ATE219050T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
HRP980438B1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
AP9701078A0 (en) Arylsulfonylamino hydroxamic acid derivatives
GB9307956D0 (en) Hydroxamic acid derivatives
HRP980058B1 (en) Arylsulfonylamino hydroxamic acid derivatives
GB9626637D0 (en) Percarboxyilic acid solutions
GB9623908D0 (en) Amino acid derivatives
HRP980070B1 (en) Arylsulfonyl hydroxamic acid derivatives
AP9901504A0 (en) Bicyclic hydroxamic acid derivatives
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en) Amidocarboxylic acid derivatives
GB9411598D0 (en) Hydroxamic acid derivatives
EP0774965A4 (fr) Derives de l'acide phenoxyphenylacetique
HUP9903892A3 (en) Hydroxamic acid derivatives
ZA9510888B (en) 3-aryl-tetronic acid derivatives
AU1812197A (en) Hydroxamic acid derivatives
AU5319898A (en) Glyoxylic acid amides
SI1003720T1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
GB9408183D0 (en) Hydroxamic acid derivatives
HU9401969D0 (en) Hydroxamic acid derivatives
ZA978800B (en) Hydroxamic acid derivatives.
ZA95301B (en) Furazancarboxylic acid derivatives
SI0977733T1 (en) Arylsulfonylamino hydroxamic acid derivatives
GB9402815D0 (en) Polypyrrolecarboxamidonaphthalenic acid derivatives
HUP9902866A3 (en) Cytostatic hydroxamic acid derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees